Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients’ Blood using Hydrogel-based Cell Block Formation
Author:
Funder
Ministry of Trade, Industry and Energy
National Cancer Center
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-33464-1.pdf
Reference53 articles.
1. Xenidis, N. et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol 27, 2177–2184, https://doi.org/10.1200/JCO.2008.18.0497 (2009).
2. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235–1239, https://doi.org/10.1038/nature06385 (2007).
3. Shen, Q. et al. Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates. Adv Mater 25, 2368–2373, https://doi.org/10.1002/adma.201300082 (2013).
4. Gorges, T. M. et al. Circulating tumor cells escape from epcam-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12, 178 (2012).
5. Huang, T. et al. Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip. Biosens Bioelectron 51, 213–218, https://doi.org/10.1016/j.bios.2013.07.044 (2014).
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway;Medical Oncology;2024-01-11
2. Diagnostic liquid biopsy biomarkers in renal cell cancer;Nature Reviews Urology;2023-09-27
3. Diagnostic liquid biopsy biomarkers in renal cell cancer;NAT REV UROL;2023
4. Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma;International Journal of Molecular Sciences;2023-05-07
5. Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?;Cancers;2022-12-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3